Back to trial detailsIntake questionnaire
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Applying to University of New Mexico Cancer Center · Albuquerque, New Mexico
Answer a few short questions to share with the research team.
0 of 3 answered